Janus Henderson Global Life Sciences Fund OCSE:NOVO B Holdings History
Janus Henderson Global Life Sciences Fund's Novo Nordisk AS Holding Summary
As of 2025-03-31, JANUS INVESTMENT FUND held 1.63 Mil shares of Novo Nordisk AS(OCSE:NOVO B), totaling kr112.74 Mil. This investment constitutes 2.66% of their stock portfolio, and JANUS INVESTMENT FUND now holds 0.04% of the outstanding Novo Nordisk AS(OCSE:NOVO B) stock.
The initial trade took place in 2021Q4. And since then Janus Henderson Global Life Sciences Fund has made 5 purchases of OCSE:NOVO B, at an average price of kr507.74, for a total of 2.47 Mil shares. In addition, there have been 8 sales at an average price of kr599.77 for 842,230.00 shares. Based on historical transaction data and OCSE:NOVO B's current price of kr423.90, Janus Henderson Global Life Sciences Fund's estimated gain on his OCSE:NOVO B holdings is kr-58.85 Mil, reflecting a -4.70% gain to date.
Janus Henderson Global Life Sciences Fund OCSE:NOVO B (kr423.90) Holding Chart
Janus Henderson Global Life Sciences Fund OCSE:NOVO B (kr423.90) Quarterly Buys and Sells
| Period | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Avrg. Price |
|---|---|---|---|---|
| Shares Bought | 0 | Average Price kr-/Share | ||
| Shares Sold | 0 | Average Price kr-/Share | ||
| Current Price kr0.00 | Total Estimated Gain 0 % | |||
Top Ranked Articles
- 1
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
